GLP-3 (Retatrutide)
Triple-agonist metabolic research compound studied in preclinical models of energy balance and body composition.
Every batch, independently verified.
Each batch is analyzed by an independent, accredited third-party laboratory before it ships. This is the released report for the batch currently in stock, with the laboratory values exactly as they were published for that lot.
Every batch on record
Open the published report for any lot on record. Your order ships with its own lot-specific report.
About GLP-3 (Retatrutide)
Retatrutide (LY3437943) is a single lipidated peptide engineered to act on three receptors at once: the glucose-dependent insulinotropic polypeptide (GIP) receptor, the glucagon-like peptide-1 (GLP-1) receptor and the glucagon receptor. That triple-agonist profile makes it a reference compound for laboratory work on incretin and glucagon receptor signaling, and for comparing single, dual and triple agonism in cell-based models. Supplied as a lyophilized powder in 10, 20 and 30 mg vials.
Not for human, veterinary, or food use. This product is sold exclusively for research and educational purposes. It is not intended to diagnose, treat, cure, or prevent any disease.
All research findings presented on this page are sourced from peer-reviewed journals and official publications. They are provided for educational reference only and should not be interpreted as medical advice or product claims.
By purchasing this product, you confirm that you are a qualified researcher and will use it in accordance with all applicable laws and regulations. See our Disclaimer and Terms of Service.
Related products
Lab guides
Protocols and background reading for working with this compound.